Renerve Limited · ASX:RNV
Renerve — Investor Presentation (June 2025)
15 slides from Renerve's investor presentation, Jun 3, 2025
Slide 1: Transforming Nerve Repair Through Science
For personal use only ASX:RNV Transforming Nerve Repair Through Science Investor Update | June 2025 Berkeley Biologics Partnership (Announced 2 June 2025)
Slide 2: Important Notice & Disclaimer
Important Notice & Disclaimer Nature of Document: This presentation has been prepared and issued by ReNerve Ltd (Company) to provide general information about the Company. The information in this document is in summary form and should not be relied upon as a complete and accurate representation of a
Slide 3: Executive Summary
Executive Summary Development of Novel Nerve Repair & Regenerative Tissue Products For personal use only ReNerve is focused on developing a portfolio of products for the nerve repair and regenerative tissue markets, with clearly defined commercial demand. Significant Product Portfolio ReNerve curren
Slide 4: ReNerve's Opportunity
ReNerve’s Opportunity Nerve Cuff Nerve Conduit Nerve Guide Matrix Bionic Nerve For personal use only • Used on damaged or transected • Improved Nerve Cuff developed from • An ‘off-the-shelf’, ready to use nerve • An ‘off-the-shelf’, continuous nerve Product nerves with no gaps or gap closure scCO2 t
Slide 5: The Berkeley Biologics Partnership
The Berkeley Biologics Partnership For personal use only Why? Synergies for ReNerve • Provides immediate products into the company • Produced through proprietary technology with portfolio and therefore sales. strong science to the benefit of patients • Products now approved for the US market. • Two
Slide 6: Global Dermal & Amniotic Tissue Repair Markets
Dermal & Amniotic Tissue Sales for Specific Surgical Applications in USD$M $2,500.00 For personal use only Global Dermal $2,000.00 & Amniotic $1,500.00 Tissue Repair $1,000.00 Markets $500.00 $0.00 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 Orthopedics (Tendon and Ligament Repa
Slide 7: Dermal product range
For personal use only range Dermal product
Slide 8: In Keeping with ReNerve Core Innovate Products
In Keeping with ReNerve Core Innovate Products Produced using proprietary processes, whilst retaining physiological benefits. For personal use only Preserve Natural Matrix Maintains structure like unprocessed dermis for improved tissue repair. Key Features of Porous Structure Facilitates faster cell
Slide 9: Key Benefits
Key Benefits Unprocessed For personal use only Designed and processed to preserve the natural matrix as closely as possible to Dermal Tissue unprocessed dermis for optimal tissue repair and regeneration. Closest to natural dermal tissue, compared to other dermal products1. New ReNerve Achieves high
Slide 10: Amniotic product ranges
For personal use only Amniotic product ranges
Slide 11: Highly Complimentary Products Used Across Procedures
Highly Complimentary Products Used Across Procedures Most nerve repairs are related to some type of wound and require some level of wound care – particularly in plastic, micro, orthopaedic and trauma surgery. Key Features of For personal use only Amniotic Product Ideal Wound Covering Options for Cha
Slide 12: Partnership Highlights
Partnership Highlights For personal use only In-Market Products Diverse Product Portfolio Immediate Market Need Gives ReNerve two new synergistic Expands the product The new products are used by product ranges coming to market portfolio with surgeons with an immediate within months to build sales co
Slide 13: Near Term Milestones - 2025
Near Term Milestones - 2025 1H 2025 2H 2025 Near Term For personal use only 27 February 2025 Additional NervAlign® Nerve Cuff Progression of the Nerve Partnership Signed for Mexico Market Clinical Data Guide Matrix to Stage 3 of Development March 2025 NervAlign® Nerve Conduit into Market Clinical St
Slide 14: Investment Highlights
Investment Highlights For personal use only In Market Product Immediate Market Need Growing Market Anticipated 4 product ranges in market by the Clear market need for all products especially Nerve repair biomaterials market is end of the year with the two new product given the strong science behind
Slide 15: Contact
For personal use only ASX:RNV Contact ReNerve Limited +61 (03) 9482 3940 info@renerve.com.au Level 10/99 Queen St, Melbourne, Victoria 3000 Australia